Conformis hip system cleared by FDA

Medical technology company Conformis' Cordera Hip System was given 510(k) clearance by the U.S. Food and Drug Administration, according to a press statement Sept. 29.

The Cordera Hip System is a total hip replacement comprising femoral and acetabular components, the statement said. Instances when it would be used include treating a painful or disabled joint from osteoarthritis, treatment of non-unions of the hip and revising previous failed hip surgery.

"Our new Cordera Hip System is the first expansion of our growing total hip portfolio. The system, which is inserted using an anterior or posterior surgical approach, will allow surgeons to treat a wider range of patients effectively," Mark Augusti, Conformis president and CEO, said in a statement. "And surgeons have the option to select an accompanying personalized surgical plan and best in class PSI guides provided through a safe, sterile, and efficient model for hospitals and ambulatory surgery center sites of care."

Read the full press release here.


Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast